Klippel KF - Search Results

1

Immunotherapy in bladder cancer with keyhole-limpet hemocyanin: a randomized study.

Jurincic CD, Engelmann U, Gasch J, Klippel KF. Jurincic CD, et al. Among authors: klippel kf. J Urol. 1988 Apr;139(4):723-6. doi: 10.1016/s0022-5347(17)42610-3. J Urol. 1988. PMID: 3127600 Clinical Trial.

2

Efficacy of local Bacillus Calmette-Guérin treatment in superficial bladder cancer relapsing under Keyhole-Limpet Hemocyanin immunotherapy.

Jurincic-Winkler C, Engelmann U, Beuth J, Klippel KF. Jurincic-Winkler C, et al. Among authors: klippel kf. Zentralbl Bakteriol. 1995 Oct;282(4):409-15. doi: 10.1016/s0934-8840(11)80712-7. Zentralbl Bakteriol. 1995. PMID: 9810664

3

Keyhole limpet hemocyanine can enhance the natural killer activity of patients with transitional cell carcinoma of the bladder.

Moltó LM, Carballido J, Jurincic C, Lapeña P, Manzano L, Salmerón I, Klippel KF, Alvarez-Mon M. Moltó LM, et al. Among authors: klippel kf. Eur Urol. 1991;19(1):74-8. doi: 10.1159/000473584. Eur Urol. 1991. PMID: 2007423

4

[Adjuvant immunotherapy with keyhole limpet hemocyanin in category PT 2 N+ and PT 3-4, No-N+, Mo renal cell carcinoma].

Jurincic-Winkler CD, Horlbeck R, von der Kammer H, Scheit KH, Klippel KF. Jurincic-Winkler CD, et al. Among authors: klippel kf. Wien Klin Wochenschr. 1994;106(14):455-8. Wien Klin Wochenschr. 1994. PMID: 7941592 Clinical Trial. German.

5

[Immunotherapy use of keyhole-limpet hemocyanin in the treatment of bladder cancer. Preliminary study].

Jurincic CD, Engelman U, Gasch J, Klippel KF. Jurincic CD, et al. Among authors: klippel kf. Arch Esp Urol. 1987 May;40(4):254-8. Arch Esp Urol. 1987. PMID: 3307646 Clinical Trial. Spanish. No abstract available.

6

Effect of keyhole limpet hemocyanin (KLH) and bacillus Calmette-Guérin (BCG) instillation on carcinoma in situ of the urinary bladder.

Jurincic-Winkler C, Metz KA, Beuth J, Sippel J, Klippel KF. Jurincic-Winkler C, et al. Among authors: klippel kf. Anticancer Res. 1995 Nov-Dec;15(6B):2771-6. Anticancer Res. 1995. PMID: 8669862 Clinical Trial.

7

Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma.

Jurincic-Winkler CD, von der Kammer H, Beuth J, Scheit KH, Klippel KF. Jurincic-Winkler CD, et al. Among authors: klippel kf. Anticancer Res. 1996 Jul-Aug;16(4A):2105-10. Anticancer Res. 1996. PMID: 8712751 Clinical Trial.

8

Urinary interleukin-1 alpha levels are increased by intravesical instillation with keyhole limpet hemocyanin in patients with superficial transitional cell carcinoma of the bladder.

Jurincic-Winkler CD, Gallati H, Alvarez-Mon M, Sippel J, Carballido J, Klippel KF. Jurincic-Winkler CD, et al. Among authors: klippel kf. Eur Urol. 1995;28(4):334-9. doi: 10.1159/000475077. Eur Urol. 1995. PMID: 8575503

9

Immunohistological findings in patients with superficial bladder carcinoma after intravesical instillation of keyhole limpet haemocyanin.

Jurincic-Winkler C, Metz KA, Beuth J, Engelmann U, Klippel KF. Jurincic-Winkler C, et al. Among authors: klippel kf. Br J Urol. 1995 Dec;76(6):702-7. doi: 10.1111/j.1464-410x.1995.tb00760.x. Br J Urol. 1995. PMID: 8535712

10

[Urothelial cancer of the upper urinary tract].

Jurincic-Winkler C, Horlbeck R, Gasser A, Glenewinkel J, Klippel KF. Jurincic-Winkler C, et al. Among authors: klippel kf. Urologe A. 1993 Jul;32(4):295-9. Urologe A. 1993. PMID: 8372411 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results